Market Overview

Erivedge 2017 U.S. Promotional Audit Report -


The "Erivedge
2017 U.S. Promotional Audit Report"
report has been added to's

The 5 Key Questions Addressed by this Report:

  • How many physicians were reached by Erivedge through reportable
    promotional activity in 2017 and how does this compare to its peer set
    in the Basal Cell Carcinoma market?
  • What promotional mix was leveraged (e.g., sales rep detailing,
    physician education, and paid speaking) and what was the median spend
    for each type of activity?
  • How does Genentech's depth of coverage vary within key specialties
    (e.g., Dermatology, Hematology/Oncology, and Medical Oncology) and how
    does this compare to its peers and the overall set of rep-accessible
  • How often are physicians receiving paid meals for Erivedge throughout
    the year (e.g., monthly, quarterly, annually)?
  • Who were the most frequent meal recipients and top paid speakers for
    Erivedge in 2017?

Data Sources and Methodology:

  • The author leverages company-reported financial transaction data
    disclosed through CMS Open Payments. This data set captures all
    transfers of value (e.g., speaking fees, consulting fees, travel,
    education, and meals) made on behalf of a drug or device manufacturer
    to a physician. More than four years of longitudinal data is available
    - covering payments to more than 975,000 U.S. healthcare professionals.
  • Over 6,300 paid interactions across 3,200 physicians made on behalf of
    Erivedge were carefully examined to support our analysis.

View Comments and Join the Discussion!